Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering
Sacramento - Today, Affymetrix, Inc.announced plans to make eight new GeneChip(R) plant and animal genomearrays available in 2005 as part of its Consortia Program, includingcanine, Rhesus macaque, Medicago trancatula (legume), Brassica, tomato,citrus, poplar and sugar cane. More than 20 research presentations atthis week's Plant and Animal Genome Conference XIII in San Diego,Calif. feature...Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
Foreveryone doing or reading a paper about microarray-based experiments,reproductibility, especially inter-lab, is the #1 concern. Can I trustthese results? If I redo the same experiment in one month, will I beable to compare both? The NIH recently demonstrated that microarrays experiments performed in d...Breakthrough Microarray-based Technology for the Study of Cancer
A new development in the analysis of cancerhas been announced by Agilent Technologies. The company has reported aninnovative method that enables the rapid advance of microarray-basedcomparative genomic studies in cancer. According to the reportpublished in the December 24, 2004 issue of the Proceedings of theNational Academy of Science (PNAS) in collaboration with the NationalHuman Genome R...Nanogen Issued Patent for Electronic Microarray With Memory
Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today that it was issued U.S. Patent No. 6,867,048, "Multiplexed Active Biologic Array" by the U.S. Patent and Trademark Office. The '048 patent relates to a method of addressing one or more electrodes (or "test sites") across multiple rows and columns of a microarray. The patent also covers a method for storing th...An entropy-based gene selection method for cancer classification using microarray data
Accurate diagnosis of cancer subtypes remains a challenging problem. Building classifiers based on gene expression data is a promising approach; yet the selection of non-redundant but relevant genes is difficult. The selected gene set should be small enough to allow diagnosis even in regular clinical laboratories and ideally identify genes involved in cancer-specific regulatory pathways. Here an...DNA/RNA Aptamer Microarray - Comprehensive Service from LC Sciences
Description:LC Sciences provides unique aptamer microarray services using a novel Paraflo technology, aptamer sequence databases, and sequence design software to suit your needs for basic research and screening of aptamers as drug candidates. This comprehensive service includes assistance with sequence design, synthesis of standard or custom DNA/RNA (2-OMe) microarrays, binding assays using proteins, nucleic...Rapid-Screen Arrayed cDNA Library Panels Master Plates -Human Placenta from OriGene Technologies
Description:The Rapid-Screen cDNA Library Panels were designed for full-length gene cloning and require just three sets of PCRs to identify the desired cDNA clone. The first PCR analysis is performed in a 96-well "Master Plate," where each well contains plasmid DNA from 5,000 clones. Having identified the positive well(s) by gel electrophoresis of the reaction products, the second PCR analysis is carried out...Rapid-Screen Arrayed cDNA Library Panels Master Plates -Human Heart from OriGene Technologies
Description:The Rapid-Screen cDNA Library Panels were designed for full-length gene cloning and require just three sets of PCRs to identify the desired cDNA clone. The first PCR analysis is performed in a 96-well "Master Plate," where each well contains plasmid DNA from 5,000 clones. Having identified the positive well(s) by gel electrophoresis of the reaction products, the second PCR analysis is carried out...Rapid-Screen Arrayed cDNA Library Panels Master Plates -Mouse Testis from OriGene Technologies
Description:The Rapid-Screen cDNA Library Panels were designed for full-length gene cloning and require just three sets of PCRs to identify the desired cDNA clone. The first PCR analysis is performed in a 96-well "Master Plate," where each well contains plasmid DNA from 5,000 clones. Having identified the positive well(s) by gel electrophoresis of the reaction products, the second PCR analysis is carried out...New Microarray Labeling Kit for Preparing cDNA Probes
A more reliable and reproducible way to create fluorescently orradioactively labeled cDNA David T. Wong Heidi Davis Darryl Garrison TerryPayette Matt Lundy Kim Kuplent Mary A. Buchanan Joseph A. Sorge Rebecca L. Mullinax Stratagene Phenogenex Nucleic acid micro...Innovative Tissue Array Technology for High-Throughput Screening of Gene Expression
Stratagene tissue arrayslides offer further refinement of tissue array technology through optimizedtissue fixation and processing procedures that preserve tissue morphology,antigenicity of pr...Human Universal cDNA Library Array I
Jean-Michel Llias Leonardo de Leon Bruce Jerpseth Sandra Soares Stratagene Stratagene has organized over 145,000 high-quality clones from a universal cDNA libra...Stratagenes Human cDNA Microarrays: Perform Gene Expression Profiling and Discover New Genes
New GeneConnection discovery microarrays provide more than 4,000 uniquehuman cDNA sequences Stratagene introduces the first in a series of human cDNA microarrays on glass slides. These GeneConnection discovery microarrays which are based on the technology published by Schena et al., can be...Arrayer Punch Set, 1.0 mm, for ATA100, Recipient & Donor, Needles, Styli, & Collets
Description:Punch set for Advanced Tissue Arrayer, 1.0 mm...Arrayer Punch Set, 0.6 mm, for ATA100, Recipient & Donor, Needles, Styli, & Collets
Description:Punch set for Advanced Tissue Arrayer, 0.6 mm...Arrayer Punch Set, 2.0 mm, for ATA100, Recipient & Donor, Needles, Styli, & Collets
Description:Punch set for Advanced Tissue Arrayer, 2.0 mm...Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
BOULDER, Colo.--(BUSINESS WIRE)--Jul 5, 2007 - Array BioPharma Inc.(Nasdaq: ARRY) today announced that its Chief Executive Officer,Robert E. Conway, will speak at the C.E Unterbeg, Towbin EmergingGrowth Conference on July 10 in New York City. The public iswelcome to participate in the conference through a webcast on theArray BioPharma website. -0- Event: C.E Unterbeg, Towbin E...Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs
BOULDER, Colo.--(BUSINESS WIRE)--Jun 20, 2007 - Array BioPharmaInc. (Nasdaq: ARRY) announced new Phase 1 clinical data on its MEKinhibitor, ARRY-162, and its p38 inhibitor, ARRY-797. These resultswere presented at the Annual European Congress of Rheumatology(EULAR) in Barcelona, Spain, and at the International Associationof Inflammation Societies' (IAIS) 8th World Congress onInflammation in...